{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreice4tjxsgmknbqb7qci2le75hdvmlgpv35mld54ccwqmxanze6jaq",
    "uri": "at://did:plc:7nuyhqvd4a6xquezhjhvregv/app.bsky.feed.post/3mkvi2jyhiid2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreihjjwvvzlklfg4nhzveyjieatshc4f6mbtlf2b2piyqfw4w4xfgsa"
    },
    "mimeType": "image/jpeg",
    "size": 465900
  },
  "path": "/2026/05/02/us/politics/supreme-court-mail-abortion-pill.html",
  "publishedAt": "2026-05-02T17:58:44.000Z",
  "site": "https://www.nytimes.com",
  "tags": [
    "United States Politics and Government",
    "Abortion",
    "Abortion Drugs",
    "Federal Courts (US)",
    "Telemedicine",
    "Drugs (Pharmaceuticals)",
    "Supreme Court (US)",
    "Food and Drug Administration",
    "Danco Laboratories",
    "Duncan, Kyle (1972- )",
    "Trump, Donald J"
  ],
  "textContent": "A federal appeals court temporarily halted a Food and Drug Administration regulation that has greatly expanded access to the abortion pill mifepristone.",
  "title": "Supreme Court Asked to Restore Access to Abortion Pill by Mail"
}